✦ LIBER ✦

Efficacy and safety of pegylated interferon alpha-2a (40 KD) plus ribavirin for treatment of chronic hepatitis C and cirrhosis in Iranian patients

✍ Scribed by B. Hajarizadeh; S. Alavian

Book ID: 116196132
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 52 KB
Volume: 33
Category: Article
ISSN: 1527-3296
DOI: 10.1016/j.ajic.2005.04.118

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

617 EFFICACY AND SAFETY OF PEGYLATED INT

617 EFFICACY AND SAFETY OF PEGYLATED INTERFERON- ALPHA PLUS RIBAVIRIN COMBINATION THERAPY IN OLD AGE CHRONIC HEPATITIS C PATIENTS

✍ C.-Y. Dai; C.-F. Huang; M.-L. Yu; J.-F. Huang; W.-L. Chuang 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Efficacy and safety of peginterferon alf

Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis

✍ Savino Bruno; Mitchell L. Shiffman; Stuart K. Roberts; Edward J. Gane; Diethelm 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB 👁 1 views

The objective of this study is to determine the efficacy and safety of peginterferon alfa-2a (40 KD)/ribavirin in patients with advanced fibrosis. Data from 341 genotype 1/4 patients (99 with bridging fibrosis/cirrhosis) treated for 48 weeks and 1547 genotype 2/3 patients (380 with bridging fibrosis

Efficacy and safety of pegylated (40-kd)

Efficacy and safety of pegylated (40-kd) interferon α-2a compared with interferon α-2a in noncirrhotic patients with chronic hepatitis C

✍ K.Rajender Reddy; Teresa L. Wright; Paul J. Pockros; Mitchell Shiffman; Gregory 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Efficacy and safety of pegylated interfe

Efficacy and safety of pegylated interferon alpha-2a therapy for chronic hepatitis C in HIV-infected patients with haemophilia

✍ R.-F. ZHANG; H.-Q. SUN; Q. HUANG; J.-R. WANG; X.-X. ZHANG; X.-N. LIU; Q. MA; H.- 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

PIN81 Cost-Effectiveness Analysis of Peg

PIN81 Cost-Effectiveness Analysis of Peg-Interferon Alpha-2A Plus Ribavirin Versus Conventional Interferon Alpha-2A Plus Ribavirin for the Treatment of Chronic Hepatitis C in China

✍ W. Chen; L. Wei 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

A randomized controlled trial of pegylat

A randomized controlled trial of pegylated interferon α-2a (40 KD) or interferon α-2a plus ribavirin and amantadine vs interferon α-2a and ribavirin in treatment-naïve patients with chronic hepatitis C

✍ A. Mangia; G. L. Ricci; M. Persico; N. Minerva; V. Carretta; D. Bacca; M. Cela; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB